Enzo Biochem Inc (ENZ)
NYSE
Quarter End | Jul 2022 | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 20.28M | 18.28M | 16.34M | 16.11M | -19.66M | 7.81M | 8.55M | 8.02M |
Operating Income | -8.12M | -9.91M | -12.98M | -15.65M | 13.8M | -5.48M | -2.18M | -2.05M |
Pre Tax Income | -8.43M | -10.64M | -11.32M | -15.19M | 12.12M | -5.68M | -863k | -2.13M |
Net Income | -8.43M | -10.64M | -11.32M | -15.19M | 57.43M | -6.62M | -3.06M | -3.02M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -8.1M | -9.91M | -12.85M | -15.5M | 13.9M | -5.32M | -2.06M | -1.95M |
EBITDA | -7.43M | -9.11M | -12.35M | -15M | 14.41M | -5.21M | -1.91M | -1.71M |
Year End July 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 160.02M | 107.8M | 104.71M | 110.1M | 76.02M | 117.73M | 107.07M | 31.06M |
Operating Income | 47M | -3.07M | -12.16M | 1.73M | -30.37M | 692k | -15.01M | -24.74M |
Pre Tax Income | 46.52M | -2.42M | -11.42M | 2.49M | -28.52M | 7.88M | -18.26M | -25.02M |
Net Income | 45.29M | -2.5M | -22.39M | 2.49M | -28.52M | 7.88M | -18.26M | 20.29M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.59 | -0.033 | -0.288 | 0.032 | -0.364 | 0.081 | -0.188 | 0.207 |
EBIT | 47.13M | -2.94M | -12M | 2.12M | -29.88M | 7.6M | -16.2M | -24.36M |
EBITDA | 50.84M | 532k | -9.03M | 4.77M | -27.59M | 3.35M | -12.18M | -22.05M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.